Trial site
Retina-Vitreous Associates Medical Group
- 24running trials
- 13closed trials
The trials here
What the 37 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration19 trials
- Diabetic eye disease14 trials
- Retinitis pigmentosa3 trials
- Phase
- Phase 218 trials
- Phase 38 trials
- Phase 14 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting15 trials
- Completed11 trials
- Recruiting6 trials
- Not yet recruiting2 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- AbbVie3 trials
- Boehringer Ingelheim3 trials
- Hoffmann-La Roche3 trials
- EyePoint Pharmaceuticals, Inc.2 trials
- Genentech, Inc.2 trials
- and 21 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Active, not recruiting
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Active, not recruiting
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
Recruiting
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (GLOBALIGHT)
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration7 recruiting
- Diabetic eye disease2 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Completed
Completed
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
Completed
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
Completed
Terminated
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
Recruiting
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Site data: ClinicalTrials.govUpdated 18 Nov 2026